March 05, 2015 6:58 AM ET


Company Overview of Premune AB

Company Overview

Premune AB, an animal health company, develops treatments for allergies, inflammatory bowel diseases, and other immune disorders in pets worldwide. Its developments are targeting problem areas in veterinary medicine. The company was founded in 2009 and is based in Stockholm, Sweden.

Kungsgatan 3 vån 4

Stockholm,  111 43


Founded in 2009


46 7 60 26 52 69

Key Executives for Premune AB

Co-Founder and Chief Executive Officer
Chief Financial Officer
Age: 57
Chief Operating Officer
Head of Licensing & Regulatory Affairs and Director
Age: 62
Head of Clinical Development
Compensation as of Fiscal Year 2014.

Premune AB Key Developments

Premune AB Presents at 8th Annual OneMedForum 2015, Jan-12-2015 03:15 PM

Premune AB Presents at 8th Annual OneMedForum 2015, Jan-12-2015 03:15 PM. Venue: San Francisco Marriott Marquis, Parc 55 Wyndham, Union Square, San Francisco, California, United States. Speakers: Viktor Karlsson, Co-Founder and Chief Executive Officer.

Premune Appoints Carl K. Johnson as Chief Medical Officer

Premune announced the appointment of Dr. Carl K. Johnson, D.V.M. as Chief Medical Officer. Johnson, who will be based in Premune's New York office and report directly to CEO Viktor Karlsson, will be responsible for Premune's global product development initiatives. Johnson is the most recent senior-level hire since the Company announced the establishment of its U.S. office on April 15, 2014. Johnson joins Premune with more than 25 years of experience in animal health. Most recently, he was Global Head of Project and Portfolio Management at Merial, where his team developed new pharmaceutical and biological products including, NexGard, which is used for the treatment of fleas and ticks, and Broadline.

Premune Appoints Eileen Daloia as Head of Regulatory Affairs

Premune announced the appointment of Eileen Daloia as Head of Regulatory Affairs. Ms. Daloia, who will be based in Premune's New York office and report directly to CEO Viktor Karlsson, will oversee all regulatory initiatives associated with the approval of the company's veterinary treatment product candidates. Ms. Daloia is the third senior-level hire since the company announced its U.S. subsidiary on April 15, 2014, joining Michio Soga, CFO and Mickey McDermott, Global Head of Marketing. Most recently, she was Director, Regulatory Affairs -- US and Canadian Divisions for Virbac Animal Health, where she contributed to a number of New Animal Drug Application ("NADA") and Minor Use Minor Species ("MUMS") approvals during her three years in the position.

Similar Private Companies By Industry

Company Name Region
Affibody Medical AB (publ) Europe
Exocure Europe
CSL Behring AB Europe
InDex Pharmaceuticals AB Europe
ProNoxis AB Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Premune AB, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at